Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.34%, DAX +0.64%, CAC40 +0.15%

Jun 20 ,2025

  • Synopsis

    • European equity markets indicate a higher open amidst mixed session in Asia and lower US futures. Bonds steady. US 10-year at 4.39%. Dollar mostly softer. Oil gains. Gold down. Industrial metals lower.

    • In latest Middle East developments, White House Press Secretary Karoline Leavitt said President Trump will decide within two weeks whether to strike Iran. Extended timeline follows reports Wednesday Trump privately approved attack plans, but no final decision made. Trump's new diplomatic window due to "substantial" chance of negotiations and reports US envoy Witkoff engaging in behind-the-scenes talks with Iran's foreign minister. Crude still reactive to headline volatility, though some semblance of stabilization in recent days amid diplomacy talk.

    • On trade front, Japan's top negotiator Akazawa said he doesn't see 9-Jul as deadline for US trade negotiations and has yet to schedule next round of talks. Comes after PM Ishiba and Trump failed to make progress at G7 meeting with Trump saying Japan being too tough in trade talks. Japan's auto trade surplus with US said to be key sticking point negotiations. Elsewhere, Vietnam and US held online talks Thursday though nothing substantive on the key issues such as Chinese transshipment practices.

    • On the agenda for today in Europe, in central banks, ECB's latest Economic Bulletin released at 10:00CET. ECOFIN meeting, ECB's de Guindos, EU's Šefčovič among the participants. ECB's Machado panelist at 15:45CET at Bank of Spain Legal Conf. EU Health Council meeting. Italy hosts The Mattei Plan for Africa and the Global Gateway with PM Meloni and EU's von der Leyen among the participants.

    • Light on the earnings front today with Berkeley Group Holdings (BKG.LN) and Record (REC.LN) out of the UK scheduled to report.

    • In macroeconomic releases, Germany May PPI and UK May retail sales are due at 7:00 BST, followed by France Jun business confidence at 7:45 BST; Eurozone Jun flash consumer confidence is due at 15:00 BST.

  • Politics/Macro/World News

    • Trump will decide within two weeks whether to strike Iran (BBC )

    • UK's Lammy to meet European counterparts in Geneva to hold nuclear talks with Iran (Reuters )

    • Spain to Challenge NATO Spending Target Increase (Bloomberg )

    • EU's Dombrovskis says 'Making progress' in trade talks With US (Bloomberg )

  • Top company news

    • Earnings/updates

      • ETL.FP (Eutelsat Communications) -- contemplates capital increase of € 1.35B, to secure the execution of its long-term strategic vision, anchored by the french state and other reference shareholders; confirms FY25 outlook

      • ALBPS.FP (Biophytis) -- Trading in Biophytis suspended by Euronext due to non-publication of its annual financial report

    • M&A

      • BAMI.IM (Banco BPM) -- UniCredit (UCG.IM) receives conditional authorization from the Directorate General for Competition (DGCOMP) for the acquisition of Banco BPM; UniCredit likely to withdraw offer for Banco BPM; to remain an investor and closely watching Commerzbank transformation -- CEO tells Repubblica

      • GREENH.DC (Green Hydrogen Systems) -- thyssenkrupp nucera (NCH2.GR) signs agreement to acquire technology assets from Green Hydrogen Systems; terms undisclosed

      • LAND.LN (Land Securities Group) -- Cheyne Capital Management and developer Stanhope expected to team up to buy Land Securities' Red Lion Court development -- Bloomberg (19-Jun. post UK close)

    • Healthcare

      • SAN.FP (Sanofi) -- FDA approves Dupixent (dupilumab) for treatment of adult patients with bullous pemphigoid (BP)

      • RLF.SW (RELIEF THERAPEUTICS Holding) -- initial request for Qualified Infectious Disease Product designation for RLF-TD011 for the treatment of epidermolysis bullosa was not granted by the US FDA

    • Other

      • ITX.SM (Inditex) -- CEO says conditions for Russia return 'certainly not' in place currently -- FT

      • VPK.NA (Royal Vopak) -- AVTL to develop ammonia terminal in Pipavav

      • NTGY.SM (Naturgy Energy Group) -- announces outcome of offer to acquire up to 88M of its shares; maximum number of shares to be acquired

      • Veolia and Waga Energy inaugurate renewable natural gas production facility in Burgundy, France

  • Key rating changes

    • Initiations:

      • BRAV.SS (Bravida Holding) -- outperform at Oddo

      • BRG.NO (Borregaard) -- buy at Danske Bank

      • VALT.LN (Valterra Platinum) -- sell at Berenberg

    • Upgrades:

      • DEMANT.DC (Demant) -- to equal weight from underweight at Barclays

      • PAG.LN (Paragon Banking Group) -- to buy from hold at Deutsche Bank

    • Downgrades:

      • AKRBP.NO (Aker BP) -- to hold from buy at Danske Bank

      • ALIF.B.SS (AddLife) -- to hold from buy at DNB Carnegie

      • CASH.SM (Prosegur Cash) -- to neutral from outperform at Santander

      • KMR.LN (Kenmare Resources) -- to hold from buy at Berenberg

      • SOON.SW (Sonova Holding) -- to underweight from equal weight at Barclays

      • WCH.GR (Wacker Chemie) -- to hold from buy at Deutsche Bank

      • YAR.NO (Yara International) -- to sell from hold at SEB; to hold from buy at Danske Bank

  • Data

    • Nikkei +0.03% to 38500.42

    • Hang Seng +0.96% to 23460.67

    • Shanghai Composite +0.14% to 3366.87

    • S&P futures (12.8) vs prior close of 6034.3

    • €-$ +0.0028 or +0.25% to 1.1526

    • $-¥ (0.01) or (0.01%) to 145.44

    • €-¥ +0.40 or +0.24% to 167.64

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE